Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Director and Participating Faculty reported the following:
Walter L. Fitzgerald, Jr, MS, JD, DPh
Dean, Pharmacy Education Program Development
• Dr Fitzgerald reports having no financial or advisory relationships with corporate organizations related to this activity.
Nelly G. Adel, PharmD, BCOP
Manager, Clinical Pharmacy Services
Oncology Residency Program Director
Memorial Sloan-Kettering Cancer Center
New York, New York
• Dr Adel reports having no financial or advisory relationships with corporate organizations related to this activity.
Notice: In accordance with ACPE Criteria for Quality, the audience is advised that an article in this CE activity contains reference(s) to unlabeled or unapproved uses of drugs or devices.
Dr Adel—paclitaxel (protein-bound particles for injectable suspension).
All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.
University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.